ID   INER-37
AC   CVCL_5621
SY   Instituto Nacional de Enfermedades Respiratorias-37
DR   BTO; BTO_0002558
DR   GEO; GSM1526648
DR   GEO; GSM1526649
DR   Wikidata; Q54897732
RX   PubMed=16271071;
RX   PubMed=26221079;
CC   Doubling time: 30 hours (PubMed=16271071); 79 hours (PubMed=26221079).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
RX   PubMed=16271071; DOI=10.1111/j.1349-7006.2005.00111.x; PMCID=PMC11158927;
RA   de Lucio B., Manuel V., Barrera-Rodriguez R.;
RT   "Characterization of human NSCLC cell line with innate
RT   etoposide-resistance mediated by cytoplasmic localization of
RT   topoisomerase II alpha.";
RL   Cancer Sci. 96:774-783(2005).
//
RX   PubMed=26221079; DOI=10.1186/s12935-015-0200-6; PMCID=PMC4517505;
RA   Barrera-Rodriguez R., Fuentes J.M.;
RT   "Multidrug resistance characterization in multicellular tumour
RT   spheroids from two human lung cancer cell lines.";
RL   Cancer Cell Int. 15:47.1-47.11(2015).
//